Fact CheckerSign in

NCT05663203Recruiting

A Web-Based Dyadic Intervention for Colorectal Cancer

A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers

Source: ClinicalTrials.gov · Last updated 5 Nov 2026

Brief summary (registry, in English)

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
56 (estimated)
First submitted
14 Dec 2022
Start date
1 May 2023
Primary completion date
1 Oct 2027
Lead sponsor
Emory University
NCT number
NCT05663203

What you commit to

  • Study type: Interventional
  • Planned participants: 56
  • From 1 May 2023 to the primary completion date, 1 Oct 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Have severe diseases (e.g., cancer, heart disease)

Other

  • Patients:
  • Karnofsky Performance Scale \< 50
    • Caregivers:

Who the study is looking for

  • Patients:
  • Age \>= 18 years
  • Diagnosed with colorectal cancer
  • Life expectancy \> 12 months
  • Receiving active chemotherapy
  • Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores)
  • Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support)
  • Access to the Internet
  • Fluent in English
    • Caregivers:
  • Age \>= 18 years
  • Primary caregiver
  • Access to the Internet
  • Fluent in English

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emory University/Winship Cancer Institute
Coordinator of this site? Confirm its status
AtlantaUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.